Shuffling of pig interleukin-2 gene and its enhancing of immunity in mice to Pasteurella multocida vaccine.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Vaccine

• Publication date

  2007-11-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2007.09.032PMID 17959278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model.

  2007cited by this paper
• Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine.

  2007cited by this paper
• Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag.

  2007cited by this paper
• Positive inductive effect of IL-2 on virus-specific cellular responses elicited by a PRRSV-ORF7 DNA vaccine in swine.

  2006cited by this paper
• Expression and purification of a mutant of human interleukin-2 in Pichia pastoris

  2006cited by this paper
• The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun.

  2006cited by this paper
• Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector.

  2006cited by this paper
• Pasteurella multocida pneumonic infection in sheep: Prevalence, clinical and pathological studies

  2006cited by this paper
• Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 gag

  2006cited by this paper
• Virulence genotype of Pasteurella multocida strains isolated from different hosts with various disease status.

  2006cited by this paper
• Interleukin-2 potentiates foot-and-mouth disease vaccinal immune responses in mice.

  2005cited by this paper
• Type I IFN is a powerful mucosal adjuvant for a selective intranasal vaccination against influenza virus in mice and affects antigen capture at mucosal level.

  2005cited by this paper
• Molecular Cloning and Expression of IL2 cDNA from the Tibet Pig

  2005cited by this paper
• The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses

  2004cited by this paper
• Regulating effects of porcine interleukin-6 gene and CpG motifs on immune responses to porcine trivalent vaccines in mice.

  2004cited by this paper
• Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice.

  2003cited by this paper
• Microparticles and nanoparticles as delivery systems for DNA vaccines.

  2003cited by this paper
• Optimized expression and specific activity of IL-12 by directed molecular evolution

  2003cited by this paper
• Adjuvant effects of IL-1β, IL-2, IL-8, IL-15, IFN-α, IFN-γ TGF-β4 and lymphotactin on DNA vaccination against Eimeria acervulina

  2001cited by this paper
• Adjuvant effects of IL-1beta, IL-2, IL-8, IL-15, IFN-alpha, IFN-gamma TGF-beta4 and lymphotactin on DNA vaccination against Eimeria acervulina.

  2001cited by this paper
• In vitro and in vivo biocompatibility of chitosan-xanthan polyionic complex.

  2000cited by this paper
• Purification of plasmid DNA using selective precipitation by compaction agents

  1999cited by this paper
• Synthetic oligodeoxynucleotides containing CpG motifs enhance immunogenicity of a peptide malaria vaccine in Aotus monkeys.

  1999cited by this paper
• Evolution of a cytokine using DNA family shuffling

  1999cited by this paper
• DNA shuffling of a family of genes from diverse species accelerates directed evolution

  1998cited by this paper
• Applications of DNA shuffling to pharmaceuticals and vaccines.

  1997cited by this paper
• Structural modifications of interleukin-2 at positions 47 and 65.

  1997cited by this paper
• Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization

  1996cited by this paper
• Influence of recombinant bovine interleukin-1 beta and interleukin-2 in pigs vaccinated and challenged with Streptococcus suis.

  1995cited by this paper
• Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-α interleukin-1 α, interleukin-2 and interferon-γ on the immunogenicity of an inactivated rabies vaccine.

  1994cited by this paper
• Rapid evolution of a protein in vitro by DNA shuffling

  1994cited by this paper
• Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-alpha, interleukin-1 alpha, interleukin-2 and interferon-gamma on the immunogenicity of an inactivated rabies vaccine.

  1994cited by this paper
• Secondary structure of human interleukin 2 from 3D heteronuclear NMR experiments.

  1992cited by this paper
• A Novel Approach to the Oral Delivery of Micro- or Nanoparticles

  1989cited by this paper
• Structure-activity studies of interleukin-2.

  1986cited by this paper
• In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

  1985cited by this paper

• Co-Expression of Pig IL-2 and Fusion Bovine Cathelicidin Gene by Recombinant Plasmids in Yeast and Their Promotion of Mouse Antibacterial Defense

  2022cites this paper
• Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants.

  2021cites this paper
• Pasteurella multocida Vaccine Candidates: A Systematic Review

  2020cites this paper
• Progress in protein engineering technology and its application and prospect in biopharmaceuticals

  2019cites this paper
• Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity.

  2017cites this paper
• DNA shuffling approach for recombinant polyvalent OmpAs against V. alginolyticus and E. tarda infections.

  2016cites this paper
• Construction and immune protection evaluation of recombinant polyvalent OmpAs derived from genetically divergent ompA by DNA shuffling.

  2016cites this paper
• Cloning of interleukin-15 gene of Tibetan pig and adjuvant effect of its recombinant plasmids packed with PEG and PEI modified chitosan nanoparticles on immunity of mice to FMD vaccination

  2015cites this paper
• Transgenic tobacco plants as production platform for biologically active human interleukin 2 and its fusion with proteinase inhibitors.

  2012cites this paper
• Advances in directed molecular evolution of reporter genes

  2012cites this paper
• Mapping quantitative trait loci for innate immune response in the pig

  2011cites this paper
• Immune response to dna vaccine expressing transferrin binding protein a gene of Pasteurella multocida

  2011cites this paper
• Porcine Interleukin-2 Expression in Insect Cells and Its Enhancement of Pig Immunity to Swine Influenza Virus Inactivated Vaccine

  2010cites this paper
• Chapter 17. Pasteurella

  2010cites this paper
• Promotion of the immunity of piglets to Hog cholera vaccine induced by shuffled pig interleukin-2 gene and CpG immunostimulatory sequences encapsulated in chitosan nanoparticles

  2010cites this paper
• Applications of Chitosan and Its Derivatives in Veterinary Medicine

  2010cites this paper
• DNA–chitosan nanoparticles improve DNA vaccine-elicited immunity against Newcastle disease virus through shuttling chicken interleukin-2 gene

  2010cites this paper
• Enhancement of the immunogenicity of an infectious laryngotracheitis virus DNA vaccine by a bicistronic plasmid encoding glycoprotein B and interleukin-18.

  2010cites this paper